Literature DB >> 8287344

Interleukin-4: new diabetes champion?

A Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8287344      PMCID： PMC1486232     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.

Authors:  D Zipris; A H Lazarus; A R Crow; M Hadzija; T L Delovitch
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

2.  Altered thymic and peripheral T-lymphocyte repertoire preceding onset of diabetes in NOD mice.

Authors:  D Zipris; A R Crow; T L Delovitch
Journal:  Diabetes       Date:  1991-04       Impact factor: 9.461

3.  Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.

Authors:  M J Rapoport; A Jaramillo; D Zipris; A H Lazarus; D V Serreze; E H Leiter; P Cyopick; J S Danska; T L Delovitch
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

4.  Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation.

Authors:  M J Rapoport; A H Lazarus; A Jaramillo; E Speck; T L Delovitch
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.